Nurse Practitioner in Staunton, IL Accepting Medicare
3 Nurse Practitioner nurses found. Showing 1 - 3
 Tonya Darr, NP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 444 N Edwardsville St, Staunton, IL 62088 Phone: 618-635-3800 Fax: 619-635-3952 |
Amber Marie Geilhausen, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 325 N Caldwell St, Staunton, IL 62088 Phone: 618-635-2221 Fax: 618-635-2269 |
Mrs. Ajin Varghese, FNP-C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 325 N Caldwell St, Staunton, IL 62088 Phone: 618-635-2221 |
News Archive
PhRMA: 460 medicines in development for rare diseases
America's biopharmaceutical research companies are intensifying research into rare diseases, which often are among the most devastating to patients and complex for researchers. A record 460 medicines for rare diseases are in late stages of the pipeline, either in clinical trials or awaiting Food and Drug Administration (FDA) review, according to a report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).
SARS-CoV-2 unique deletion variants found in clinical specimens
While participating in the SPHERES Consortium project, US researchers sequenced 2,726 clinical patient specimens gathered in March 2020 and identified eight unique ORF7a deletion variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Their results are currently available on the bioRxiv* preprint server.
Experimental Ebola vaccine appears safe, produces immune system responses in NIH phase 1 trial
An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it in a Phase 1 clinical trial conducted by researchers from the National Institutes of Health. The candidate vaccine, which was co-developed by the NIH's National Institute of Allergy and Infectious Diseases and GlaxoSmithKline, was tested at the NIH Clinical Center in Bethesda, Maryland.
CQ's Armstrong discusses proposed public health plan option; new bill on FDA tobacco regulation
Drew Armstrong, a Congressional Quarterly staff reporter, discusses the latest developments in efforts to overhaul the U.S. health care system, legislation that would give FDA regulatory authority over tobacco products and a new bill that would allow FDA to approve generic versions of biotechnology drugs in this week's "Health on the Hill from kaisernetwork.org and CQ."
› Verified 5 days ago